4 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18416590 | NOVEL SALTS OF SELECTIVE ESTROGEN RECEPTOR DEGRADERS | AULAKH, CHARANJIT | 1621 | Final Rejection | Jan 18, 2024 |
| 18515890 | Pyrimidine or Pyridine Compounds, Preparation Method Therefor and Pharmaceutical Uses Thereof | MOORE, SUSANNA | 1624 | Non-Final OA | Nov 21, 2023 |
| 18011138 | QUINAZOLINE COMPOUNDS, PREPARATION METHODS AND USES THEREOF | FETTEROLF, BRANDON J | 1626 | Non-Final OA | Dec 16, 2022 |
| 18010735 | ORAL FORMULATIONS AND USES THEREOF | BURKETT, DANIEL JOHN | 1624 | Final Rejection | Dec 15, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial